n,n-dimethylarginine has been researched along with taurine in 3 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (taurine) | Trials (taurine) | Recent Studies (post-2010) (taurine) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 10,301 | 430 | 2,438 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | taurine (IC50) |
|---|---|---|---|
| Sodium- and chloride-dependent taurine transporter | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, CP; Huang, H; Jia, SJ; Jiang, DJ; Jiang, JL; Li, YJ; Tan, B | 1 |
| Attia, JR; Carru, C; Mangoni, AA; McEvoy, M; Zinellu, A | 1 |
| Bifulco, F; Carru, C; Fois, AG; Mangoni, AA; Pirina, P; Sotgia, S; Sotgiu, E; Zinellu, A; Zinellu, E | 1 |
3 other study(ies) available for n,n-dimethylarginine and taurine
| Article | Year |
|---|---|
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Topics: Acetylcholine; Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Taurine; Time Factors; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents; Vitamin E | 2007 |
Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aging; Amidohydrolases; Arginine; Australia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Community Medicine; Cysteine; Dipeptides; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Taurine | 2013 |
Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.
Topics: Age Factors; Aged; Aged, 80 and over; Arginine; Aryldialkylphosphatase; Biomarkers; Case-Control Studies; Female; Forced Expiratory Volume; Humans; Linear Models; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sex Factors; Taurine | 2016 |